Navigation Links
Labopharm Enters Into CAD$25 Million Standby Equity Distribution Agreement
Date:11/25/2009

nada, major European markets and Australia. The Company's second product, a novel formulation of trazodone for the treatment of major depressive disorder, is under regulatory review in the U.S. and in Canada. The Company also has a pipeline of follow-on products in both pre-clinical and clinical development. Labopharm's vision is to become an integrated, international, specialty pharmaceutical company with the capability to internally develop and commercialize its own products. For more information, please visit www.labopharm.com.

This press release contains forward-looking statements, which reflect the Company's current expectations regarding future events. The forward-looking statements involve risks and uncertainties. Actual events could differ materially from those projected herein and depend on a number of factors, including the uncertainties related to the regulatory process in various countries for the approval of the Company's products and the successful commercialization of the products throughout the world if they are approved. Investors should consult the Company's ongoing quarterly filings and annual reports for additional information on risks and uncertainties relating to these forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. Except as required by law, the Company undertakes no obligation and does not intend to update these forward-looking statements.

SOURCE Labopharm Inc.


'/>"/>
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Labopharm To Present Poster On Onset Of Analgesic Effect Of Once-Daily Tramadol At Congress Of The European Society Of Regional Anaesthesia And Pain Therapy
2. Labopharm provides update on U.S. regulatory process for once-daily Tramadol
3. Labopharm completes enrolment for Phase III clinical study for its once-daily trazodone antidepressant drug
4. Labopharm appeals FDAs decision on once-daily tramadol
5. Labopharm to host conference call Friday, November 9, 2007 at 8:30 a.m. (ET)
6. Labopharm to present at CIBC World Markets 18th Annual Healthcare Conference
7. Labopharm Reports Results for Third Quarter Fiscal 2007
8. Labopharm receives FDA response to appeal of Approvable Letter for once-daily tramadol
9. Labopharm enters into licensing and distribution agreement for once-daily tramadol in Australia with iNova
10. Canadian Marketing and Sales Effort for Labopharms Once-Daily Tramadol Product to Expand Significantly
11. Labopharm Reports Positive Results for Phase III Study on Once-daily Trazodone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... , ... September 02, 2015 , ... The medical waste ... billion in 2015, at a CAGR of 5.2%. The global medical waste management market ... The treatment and disposal segment is expected to register the highest growth rate in ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... academic partnership has earned international recognition as a premier center for treatment of ... cause sudden, catastrophic internal bleeding and stroke. , Cure HHT, previously known ...
(Date:9/2/2015)... ... September 02, 2015 , ... Since 2011, DoMyOwnPestControl.com has ... to help support childhood cancer research. On June 17, 2014, the owners ... , which is the fund-raising event DoMyOwnPestControl.com sponsors each year. The very next ...
(Date:9/2/2015)... ... September 02, 2015 , ... A third party ... action after seeing a significant increase in unlawful tactics used by out-of-network (OON) ... many cases of OON ASCs encouraging members to have elective procedures done at ...
(Date:9/2/2015)... ... 02, 2015 , ... A recent survey by Consumer Reports ( http://bit.ly/1h67tL8 ) ... negative impact on consumers. It was reported that 33% are paying an average of ... as an extra $100 compared to last year. Among the drugs that saw the ...
Breaking Medicine News(10 mins):Health News:Medical Waste Management Market Growing at 5.2% CAGR to 2020 2Health News:Medical Waste Management Market Growing at 5.2% CAGR to 2020 3Health News:Medical Waste Management Market Growing at 5.2% CAGR to 2020 4Health News:Medical Waste Management Market Growing at 5.2% CAGR to 2020 5Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 2Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 3Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 4Health News:DoMyOwnPestControl.com Goes Gold for Childhood Cancer Awareness Month 2Health News:TPA Cracks Down on Forbidden Tactics Used by Out-of-Network Surgical Centers 2Health News:TPA Cracks Down on Forbidden Tactics Used by Out-of-Network Surgical Centers 3Health News:Watertree Health President Responds to Consumer Reports Survey on Rising Prescription Drug Prices 2
... commonly used to treat rheumatoid arthritis (RA) and is ... Despite its widespread use, the understanding of its mechanism ... occurs early in the course of RA and is ... levels of MTX to be reached could be useful ...
... More than 3 million people in America,have some form ... doctors and medicine. Treatment can be tough to get, ... and other medical,conditions. This National Epilepsy Awareness Month, Pfizer ... of uninsured men and women get,prescription medicines for free ...
... appear to be similar to insulin, study says , , ... by fat tissues holds promise for people with insulin ... , The hormone, called apelin, significantly lowered blood ... mice, according to a study published in the November ...
... WALTHAM, Mass., Nov. 4 Vericept, the ... intellectual property protection, is,proud to announce the ... Over 100 companies in the healthcare industry ... maintain regulatory compliance with,HIPAA, as well as ...
... monitoring,solutions and services will reshape the diabetic care ... revenues by 2013, according to Parks,Associates, Enhancing Diabetic ... update finds companies like Medtronic, Cardiocom,Diabetech, and Healthways ... to this paradigm shift in diabetic care. They ...
... November 3, 2008 (Baltimore, MD)New research published in the ... medical journal of the American Academy of Neurology, found ... than girls. By examining age-related improvement of motor skills ... Kennedy Krieger Institute in Baltimore, Md. found that girls ...
Cached Medicine News:Health News:Wide variability in rheumatoid arthritis drug suggests alternative dosing should be considered 2Health News:Wide variability in rheumatoid arthritis drug suggests alternative dosing should be considered 3Health News:Hormone Lowers Glucose Levels in Mice 2Health News:Vericept Announces 100 Customers in Healthcare Industry for Sensitive Data Protection 2Health News:New Technologies and Care Enhancement Models Will Add $1.4 Billion to the Diabetic Care Market in 2013 2Health News:Study finds ADHD affects motor skills of boys more than girls 2
(Date:9/2/2015)... 2015  ArmaGen, Inc., a privately held biotechnology ... severe neurological disorders, announced today that the first ... 1/2a clinical trial of AGT-181 in patients with ... AGT-181 is an investigational enzyme replacement therapy ... most severe form of MPS I, Hurler syndrome, ...
(Date:9/2/2015)... YORK, Pa. , Sept. 2, 2015 ... and ASX: UNS), a developer, manufacturer and supplier ... response to third-party initiated expressions of interest, the Company,s ... LLC to conduct a review of strategic alternatives to ... to be explored and evaluated during the review process ...
(Date:9/2/2015)... -- According to a new market research ... Radiography, Ultrasound, Computed & Optical Coherence Tomography, MRI, PET/CT ... Neurology) - Global Forecast to 2020", the Global Veterinary ... by 2020 growing at a CAGR of 6.6% during ... 240 Tables and 44 F igures spread through ...
Breaking Medicine Technology:ArmaGen Announces First Patient Dosed in Phase 1/2a Clinical Trial of AGT-181 for the Treatment of Hurler Syndrome 2ArmaGen Announces First Patient Dosed in Phase 1/2a Clinical Trial of AGT-181 for the Treatment of Hurler Syndrome 3ArmaGen Announces First Patient Dosed in Phase 1/2a Clinical Trial of AGT-181 for the Treatment of Hurler Syndrome 4Unilife Announces Review of Strategic Alternatives 2Veterinary Imaging Market Worth USD 2.8 Billion by 2020 2Veterinary Imaging Market Worth USD 2.8 Billion by 2020 3Veterinary Imaging Market Worth USD 2.8 Billion by 2020 4Veterinary Imaging Market Worth USD 2.8 Billion by 2020 5
PremierEdge™ Implant Knives....
Interchangeable design allows you to select a single handpiece and change tips during the procedure. Universal connector. Disassembles for easy cleaning. Tips can rotate 360 degrees to re-orient port...
Interchangeable design allows you to select a single handpiece and change tips during the procedure. Universal connector. Disassembles for easy cleaning. Tips can rotate 360 degrees to re-orient port...
Interchangeable design allows you to select a single handpiece and change tips during the procedure. Universal connector. Disassembles for easy cleaning. Tips can rotate 360 degrees to re-orient port...
Medicine Products: